Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

lupus erythematosus panniculitis News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study characterizes myocarditis associated with systemic lupus erythematosus, highlighting its transition from a rare clinical manifestation to potential subclinical involvement. This research may inform future diagnostic and treatment strategies for affected patients.

A recent study published in PubMed highlights the occurrence of simultaneous calcified and noncalcified fibrotic splenic nodules in patients with systemic lupus erythematosus. This discovery may enhance understanding of splenic manifestations in this autoimmune disease.

Alumis' TYK2 inhibitor has failed in a pivotal study for lupus, joining other TYK2 blockers that have struggled outside of psoriasis and psoriatic arthritis. Despite this setback, Alumis remains optimistic about the drug's potential in lupus.

New research highlights the role of abnormal copper metabolism in systemic lupus erythematosus, suggesting potential pathways for therapeutic intervention. This study adds to the understanding of the disease's underlying mechanisms.

A recent publication discusses early-onset systemic lupus erythematosus characterized by discoid rash and chondritis. This research contributes to the understanding of the disease's presentation and potential implications for treatment.

Research highlights that MxA expression in myocarditis associated with systemic lupus erythematosus indicates activation of the type I interferon pathway. This finding could provide insights into the underlying mechanisms of myocarditis in lupus patients.

A recent study highlights the challenges of implementing a treat-to-target approach in the routine care of lupus patients across the nation. The findings emphasize the need for improved strategies to enhance treatment outcomes in this complex disease.

A case report evaluates serum varicella-zoster virus viral load in a woman with systemic lupus erythematosus complicated by a visceral disseminated varicella-zoster virus infection. This study contributes to understanding the interaction between these conditions.

A recent study highlights large pericardial effusion as a manifestation of overlapping hydralazine-induced lupus and ANCA vasculitis. This discovery may enhance understanding of the complex interactions between these conditions.

A case series published in PubMed highlights the clinical spectrum of DNASE1L3-associated monogenic lupus through four pediatric cases from Syria. This research expands understanding of the disease's manifestations and may inform future clinical approaches.

The lupus damage index revision program has completed its item generation and reduction phases, providing insights into the assessment of damage in lupus patients. This research aims to enhance the accuracy and relevance of damage assessments in clinical settings.

Recent findings from the Lupus Damage Index Revision Program highlight significant advancements in item generation and reduction phases. These results aim to improve the assessment of damage in lupus patients, enhancing clinical evaluations.

A systematic review highlights the clinical, radiological, and endocrine features of lupus-associated hypophysitis. This condition, linked to systemic lupus erythematosus, presents unique challenges in diagnosis and management.

A recent study highlights the diagnostic challenges of autoimmune myelofibrosis secondary to systemic lupus erythematosus in resource-limited settings. This research underscores the need for improved diagnostic protocols in rare disease contexts.

A new study reports on the use of anifrolumab to target type I interferon in patients with lupus autoimmune hemolytic anemia. This research could pave the way for novel therapeutic strategies in managing this condition.

A retrospective analysis of 54 cases reveals key clinicopathological features of lupus erythematosus panniculitis. This study enhances understanding of LEP, potentially guiding future research and treatment strategies.

Recent discussions highlight the gap between innovative research and practical applications in lupus treatment. The complexities of lupus pose significant challenges for translating scientific advancements into effective therapies.

A case report highlights progressive podocyte infolding glomerulopathy in a patient with systemic lupus erythematosus, identified through serial renal biopsies. This study contributes to the understanding of renal complications associated with lupus.

A recent study highlights a rare overlap syndrome in lupus patients, presenting with both pancreatitis and nephritis. This multisystem flare underscores the complexity of managing lupus and its associated conditions.

Not rare diseases news,news about your rare disease.